drugset / Trial / NCT02788292

Effect of N-Acetylcysteine on Autologous Fat Graft Survival

NCT02788292

Phase 4 Withdrawn Nova Scotia Health Authority
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A single-centre triple-blind study looking at the addition of NAC to tumescent solution for liposuction and fat grafting in healthy patient volunteers already undergoing bilateral breast reduction. Three-dimensional reconstructions and volumetric analysis will be performed based on CT scans at 0, 1 and 3 months and then histological analysis will be performed after fat graft explantation at 3 months to determine fat graft vascularity and quality.

Timeline

Start
2016-08-15
Primary completion
2020-11-16
Completion
2020-11-16

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule